In the early morning of February 15, Huasheng diagnostic center under BGI was officially opened in the "fire eye" laboratory reset at Ma On Shan stadium in Hong Kong. Recently, the epidemic situation in Hong Kong has aroused concern. So far, many Guangdong biomedical enterprises such as BGI, Jinyu medicine and Kemp medicine have sent professional teams to Hong Kong to significantly improve their nucleic acid detection capabilities and jointly help Hong Kong fight the epidemic. "Fire eye" Laboratory 16 film 24-hour operation According to Liu Xing, deputy general manager of Huasheng Diagnostic Center Co., Ltd. and chief commander of Hong Kong "fire eye" laboratory, at present, there are 16 gas membranes in the laboratory, which are divided into two groups. Each gas membrane has different functions and is responsible for preparing reagents, splitting samples, extraction, etc. The "fire eye" laboratory operates 24 hours after restart, and the detection capacity of single tube is 10000 in the first night. It is expected to increase to 100000 single tubes per day within two weeks. According to Hu dingxu, chairman of BGI Huasheng diagnosis center, more than 200 testing personnel have been dispatched from Shenzhen and 100 to 200 local testing personnel from Hong Kong have been deployed to operate the laboratory, and will continue to dispatch personnel from Shenzhen for support. The reset "fire eye" laboratory uses many new automatic instruments, which reduces the human burden to a certain extent. "At present, the testing demand in Hong Kong has increased significantly. If we want to carry out small and medium-sized zoning testing, we need to build another 2-3 temporary gas film laboratories." At present, the second and third sets of "fire eye" laboratories are being transported to Hong Kong. After completion, it is expected to increase the daily detection volume to 900000 people. Huada said covid-19 has cooperated with Hongkong's relevant agencies since the outbreak of the new crown outbreak. In August 2020, the "fire eye" Laboratory of Huada landed for the first time in Zhongshan Memorial Park in Hong Kong to help popularize the community testing program in Hong Kong. Jinyu medicine A total of 1.5 million people were detected in Hong Kong The reporter learned from Jinyu medicine that at present, more than 70 people have been involved in the fight against the epidemic in Hong Kong, and the total number of nucleic acid tests has reached 1.5 million. Wang linglai, vice president of Jinyu medicine, introduced that on January 24 and February 10, 2022, the Hong Kong SAR government sent two letters asking Jinyu medicine to send personnel to improve the nucleic acid detection capacity of Jinyu in Hong Kong. With the efficient cooperation of relevant departments in Guangdong Province and Guangzhou, Jinyu medicine quickly transferred qualified backbone personnel from the whole country and sent 40 inspectors to Hong Kong. "At present, Jinyu medicine has more than 70 inspectors in Hong Kong, and the nucleic acid detection capacity has increased from 36000 to 70000 per day, accounting for 1 / 3 of the current capacity in Hong Kong." Jinyu said that in this round of epidemic, Jinyu medicine has undertaken tasks including the Hong Kong Hospital Authority, the Department of health, the International Airport, compulsory quarantine hotels, multiple community testing centers, nearly 20 mobile sampling points and emergency testing in enclosed areas, with a cumulative detection volume of 1.5 million people. Yan Ting, President of Jinyu medicine, said that in view of the continuous increase in the number of confirmed cases in Hong Kong, Jinyu medicine is organizing the deployment of additional testing personnel and equipment to Hong Kong in order to further cooperate with the SAR government to improve the nucleic acid testing capacity. "At present, the second laboratory of Hong Kong Jinyu has been specially approved by the SAR government. The personnel and equipment are being urgently transported and can be put into operation in the near future." Yan Ting revealed that Jinyu medicine has reserved 2-3 sets of "Falcon" hard gas membrane laboratories for deployment by the SAR government. Once put into use, the daily detection capacity of Jinyu in Hong Kong can reach 200000 people. Since 2020, with the approval of the SAR government, Hong Kong Jinyu under Jinyu medicine has officially undertaken the task of nucleic acid detection in Hong Kong, and is one of the main forces of nucleic acid detection in Hong Kong. Kemp medicine The daily output of testing reagents can reach 1 million people At more than 8 p.m., Dr. Xie Longxu, a medical scientist and deputy general manager of Kemp, had bright lights in his office in Guangzhou. He was processing the work information sent back by the Hong Kong team. "Our first set of gas film laboratory, the 'triumph' gas film laboratory, has arrived in Hong Kong and officially set up on Thursday. After the opening of the gas film laboratory and the company's original testing force in Hong Kong, the testing volume in Hong Kong this week can be increased to 110000 people per day. Dr. Xie Longxu said that after the fifth round of outbreak in Hong Kong, the first 72 dispatched personnel of the company were transferred from Guangdong company to Hong Kong for support. "The second batch of about 70 dispatched personnel from all over the country will be in place by the 17th of this month. At present, Kemp medical examination undertakes more than one-third of the testing tasks designated by the Hong Kong SAR government." It is reported that in order to better complete the anti epidemic task in Hong Kong, Kemp medicine has also made sufficient reserves of consumables, reagents and other related materials for nucleic acid testing. Up to now, the daily output of the company's new crown detection reagent can reach 1 million people, which fully meets the demand for nucleic acid detection reagents in the domestic and foreign markets. (Xinhua News Agency)